Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Mayo Clinic, Jacksonville, Florida

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Washington University in St. Louis, St Louis, Missouri

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin